Neoadjuvant immunotherapy for melanoma is now ready for clinical practice

Claus Garbe; Reinhard Dummer; Teresa Amaral; Rodabe N. Amaria; Paolo A. Ascierto; Elizabeth M. Burton; Brigitte Dreno; Alexander M.M. Eggermont; Axel Hauschild; Christoph Hoeller; Roland Kaufmann; Celeste Lebbe; Mario Mandala; Alexander M. Menzies; David Moreno; Olivier Michielin; Paul Nathan; Sapna P. Patel; Caroline Robert; Dirk Schadendorf; Paul C. Lorigan; Richard A. Scolyer; Hussein A. Tawbi; Bart A. van de Wiel; Christian Blank; Georgina V. Long

Article

Neoadjuvant immunotherapy for melanoma is now ready for clinical practice

Nature Medicine

DOI: 10.1038/s41591-023-02336-1

34Citations

27Readers

Get full text

Cite

CITATION STYLE

APA

Garbe, C., Dummer, R., Amaral, T., Amaria, R. N., Ascierto, P. A., Burton, E. M., … Long, G. V. (2023, June 1). Neoadjuvant immunotherapy for melanoma is now ready for clinical practice. Nature Medicine. Nature Research. https://doi.org/10.1038/s41591-023-02336-1

Neoadjuvant immunotherapy for melanoma is now ready for clinical practice

Cite

Register to see more suggestions